Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients
- PMID: 21674477
- DOI: 10.1002/eji.201041282
Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients
Abstract
Substantial evidence indicates that inflammation is a critical component of tumor progression. The proinflammatory IL-17-producing cells have recently been detected in tumors, but the effect of IL-17 on antigen-presenting cells in tumors is presently unknown. We recently found that B7-H1(+) macrophages (Mφs) were enriched predominantly in the peritumoral stroma of hepatocellular carcinomas (HCCs). Here, we found a positive correlation between IL-17-producing cells and B7-H1-expressing Mφs in the same area. The B7-H1(+) monocytes/Mφs from HCC tissues expressed significantly more HLA-DR, CD80, and CD86 than B7-H1(-) cells. Accordingly, IL-17 could activate monocytes to express B7-H1 in a dose-dependent manner. Although culture supernatants derived from hepatoma cells also induced B7-H1 expression on monocytes, IL-17 additionally increased hepatoma-mediated B7-H1 expression. Autocrine inflammatory cytokines released from IL-17-activated monocytes stimulated B7-H1 expression. Moreover, these IL-17-exposed monocytes effectively suppressed cytotoxic T-cell immunity in vitro; the effect could be reversed by blocking B7-H1 on those monocytes. Consistent with this, cytotoxic T cells from HCC tissues expressed significant B7-H1 receptor programmed death 1 (PD-1) and exhibited an exhausted phenotype. These data reveal a fine-tuned collaborative action between different stromal cells to counteract T-cell responses in tumors. Such IL-17-mediated immune tolerance should be considered for the rational design of effective immune-based anti-cancer therapies.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients.J Immunol. 2010 Aug 1;185(3):1544-9. doi: 10.4049/jimmunol.0904094. Epub 2010 Jun 25. J Immunol. 2010. PMID: 20581151
-
Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.Hum Reprod. 2009 Dec;24(12):3160-71. doi: 10.1093/humrep/dep308. Epub 2009 Sep 3. Hum Reprod. 2009. PMID: 19729380
-
Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.J Neuroimmunol. 2004 Oct;155(1-2):172-82. doi: 10.1016/j.jneuroim.2004.06.013. J Neuroimmunol. 2004. PMID: 15342209
-
Significance of B7-H1 overexpression in kidney cancer.Clin Genitourin Cancer. 2006 Dec;5(3):206-11. doi: 10.3816/CGC.2006.n.038. Clin Genitourin Cancer. 2006. PMID: 17239274 Review.
-
Immuno-Oncology in Hepatocellular Carcinoma: 2017 Update.Oncology. 2017;93 Suppl 1:147-159. doi: 10.1159/000481245. Epub 2017 Dec 20. Oncology. 2017. PMID: 29258079 Review.
Cited by
-
Perspectives on immune checkpoint ligands: expression, regulation, and clinical implications.BMB Rep. 2021 Aug;54(8):403-412. doi: 10.5483/BMBRep.2021.54.8.054. BMB Rep. 2021. PMID: 34078531 Free PMC article. Review.
-
Dynamic education of macrophages in different areas of human tumors.Cancer Microenviron. 2012 Dec;5(3):195-201. doi: 10.1007/s12307-012-0113-z. Epub 2012 Jun 14. Cancer Microenviron. 2012. PMID: 22696271 Free PMC article.
-
Distinct Changes of BTLA and HVEM Expressions in Circulating CD4+ and CD8+ T Cells in Hepatocellular Carcinoma Patients.J Immunol Res. 2018 Jul 18;2018:4561571. doi: 10.1155/2018/4561571. eCollection 2018. J Immunol Res. 2018. PMID: 30116751 Free PMC article.
-
Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation.PLoS Negl Trop Dis. 2022 Jun 24;16(6):e0010544. doi: 10.1371/journal.pntd.0010544. eCollection 2022 Jun. PLoS Negl Trop Dis. 2022. PMID: 35749568 Free PMC article.
-
Role of regulation of PD-1 and PD-L1 expression in sepsis.Front Immunol. 2023 Mar 9;14:1029438. doi: 10.3389/fimmu.2023.1029438. eCollection 2023. Front Immunol. 2023. PMID: 36969168 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials